As of 2026-10-11, the Relative Valuation of Precision BioSciences Inc (DTIL) is (33.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.72 USD, the upside of Precision BioSciences Inc based on Relative Valuation is -601.8%.
The range of the Relative Valuation is (18.68) - (43.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 22.6x | 18.1x |
| Forward P/E multiples | 9.1x - 21.4x | 14.9x |
| Fair Price | (18.68) - (43.70) | (33.72) |
| Upside | -378.0% - -750.3% | -601.8% |
| Date | P/E |
| 2026-10-09 | -3.25 |
| 2026-10-08 | -3.15 |
| 2026-10-07 | -3.06 |
| 2026-10-06 | -3.03 |
| 2026-10-05 | -3.09 |
| 2026-10-02 | -3.09 |
| 2026-10-01 | -3.10 |
| 2026-09-30 | -3.06 |
| 2026-09-29 | -3.02 |
| 2026-09-28 | -3.05 |
| 2026-09-25 | -3.04 |
| 2026-09-24 | -3.10 |
| 2026-09-23 | -3.11 |
| 2026-09-22 | -3.52 |
| 2026-09-21 | -3.18 |
| 2026-09-18 | -3.26 |
| 2026-09-17 | -3.26 |
| 2026-09-16 | -3.24 |
| 2026-09-15 | -3.23 |
| 2026-09-14 | -3.36 |
| 2026-09-11 | -3.51 |
| 2026-09-10 | -3.54 |
| 2026-09-09 | -3.55 |
| 2026-09-08 | -3.62 |
| 2026-09-04 | -3.65 |
| 2026-09-03 | -3.61 |
| 2026-09-02 | -3.65 |
| 2026-09-01 | -3.74 |
| 2026-08-31 | -3.74 |
| 2026-08-28 | -3.81 |
| 2026-08-27 | -4.11 |
| 2026-08-26 | -4.15 |
| 2026-08-25 | -4.18 |
| 2026-08-24 | -4.13 |
| 2026-08-21 | -4.33 |
| 2026-08-20 | -4.27 |
| 2026-08-19 | -4.16 |
| 2026-08-18 | -4.03 |
| 2026-08-17 | -3.62 |
| 2026-08-14 | -3.64 |
| 2026-08-13 | -3.57 |
| 2026-08-12 | -3.63 |
| 2026-08-11 | -3.67 |
| 2026-08-10 | -3.65 |
| 2026-08-07 | -3.66 |
| 2026-08-06 | -3.63 |
| 2026-08-05 | -3.65 |
| 2026-08-04 | -3.56 |
| 2026-08-03 | -3.45 |
| 2026-07-31 | -3.42 |